2015-12-23T07:50:07-06:00 2015-03-31 ERNST & YOUNG US LLP 425 HOUSTON STREET SUITE 600 FORT WORTH TX 76102 990 2014-04-01 751835298 SUSAN G KOMEN BREAST CANCER FOUNDATION INC % DR JUDITH SALERNO SUSA 9728551600 5005 LBJ Freeway Suite 250 Dallas TX 752446125 Dr Judith Salerno CEO and President 2015-12-23 KATHY PITTS P00292940 8173351900 2014 2016-03-07 17:11:31Z SUSAN G KOMEN Dr Judith Salerno 5005 LBJ Freeway Dallas TX 752446125 279485608 false 7164 X www.komen.org X 1982 TX AT SUSAN G. KOMEN, WE ARE COMMITTED TO ENDING BREAST CANCER FOREVER BY EMPOWERING PEOPLE,ENERGIZING SCIENCE TO FIND THE CURES AND ENSURING QUALITY CARE FOR ALL PEOPLE, EVERYWHERE 10 9 267 4654 0 91606572 77337857 23368295 20910092 12781994 23876364 -4716975 -3731604 123039886 118392709 38325752 45795848 0 0 24001926 24184105 1906359 2905078 10893656 61523637 47479191 125757674 120364222 -2717788 -1971513 282716020 240309976 155720348 124648853 126995672 115661123 X AT SUSAN G. KOMEN, WE ARE COMMITTED TO ENDING BREAST CANCER FOREVER BY EMPOWERING PEOPLE, ENERGIZING SCIENCE TO FIND THE CURES AND ENSURING QUALITY CARE FOR ALL PEOPLE, EVERYWHERE. false false 41498219 36703535 21124423 Grants to other non-profit organizations to support breast cancer research, as well as research resources and conferences that further the breast cancer research agenda. See schedule O for additional details. 38204613 3618580 0 Public health education programs to increase the public's awareness of breast cancer including, among other things, early detection and treatment. See schedule O for additional details. 17709029 5473733 0 Breast cancer screening, diagnosis and treatment programs and grants. See schedule O for additional details. 97411861 true true false true false false false false false true true true false false false true false true false false true true false true true false false true false true false false false false false false false false true false false false false false false false false true 128 0 true 267 true false false false false false true true false false false false X 10 9 false false true false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DC FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X DR JUDITH SALERNO 9728551600 5005 LBJ FREEWAY Dallas TX 752446125 Linda Custard CHAIR OF THE BOARD 30.0 0.0 X X 0 0 0 Connie O'Neill BOD Member & Treasurer 1.0 0.0 X X 0 0 0 Nancy G Brinker Board Member & Founder 55.0 0.0 X X 397093 0 25492 Jane Abraham BOD Member 1.0 0.0 X 0 0 0 Alan D Feld BOD Member 1.0 0.0 X 0 0 0 Susie Knopf BOD Member 1.0 0.0 X 0 0 0 Dr Olufunmilayo Olopade MD BOD Member 1.0 0.0 X 0 0 0 Tricia Ory BOD Member 1.0 0.0 X 0 0 0 John D Raffaelli BOD Member 1.0 0.0 X 0 0 0 Linda Wilkins BOD Member 1.0 0.0 X 0 0 0 Dr Judith Salerno President & CEO 55.0 0.0 X 479858 0 3625 Ellen Willmott Gen Counsel & Secretary 55.0 0.0 X 264156 0 24379 Lesley Lurie Assistant Secretary 55.0 0.0 X 201367 0 27147 Norman Bowling Chief Mkt/Rev Off (begin 7/14) 55.0 0.0 X 137272 0 3707 Mark Nadolny Chief Finan Officer (END 9/14) 55.0 0.0 X 293610 0 28281 Chandini Portteus CHIEF MISSION OFFCR (END 9/14) 55.0 0.0 X 281038 0 31720 David Dawson VP, Information Technology 55.0 0.0 X 156595 0 26122 Kay Merrell VP, Human Resources 55.0 0.0 X 209001 0 28528 Miguel Perez VP Affiliate Ntwrk 55.0 0.0 X 183859 0 19203 Wendy Carter Director, Global Outreach 55.0 0.0 X 175987 0 1269 Andrea Rader Managing Director, Comm. 55.0 0.0 X 163484 0 21531 Subhendu Rath Director, IT Enterprise System 55.0 0.0 X 150863 0 23689 Stephanie Birkey Reffey PHD Managing Dir. Evaluation & Out 55.0 0.0 X 152253 0 28978 Victoria Wolodzko Mng Director, Grants & PrOG AD 55.0 0.0 X 165491 0 17559 3411927 0 311230 45 false true false Event 360 Inc 205 N Michigan Avenue Chicago IL 606015927 Event Management 3531803 Merkle Response Services Inc PO Box 64897 Baltimore MD 21264 Donation processing 2896302 Blackbaud Inc PO Box 930256 Atlanta GA 311930256 Donation processing 1349278 Slingshot LLC 208 N Market Street Dallas TX 75202 Marketing services 1236625 Adecco Employment Services 175 Broadhollow Road Melville NY 11747 Temp Staffing Svcs 1174196 25 792381 27699502 48845974 73247 77337857 AFFILIATE PAYMENTS 900099 20910092 20910092 0 0 20910092 3430446 3430446 0 111677 111677 0 0 0 175552675 155106757 20445918 20445918 20445918 1250967 27699502 5462211 -4211244 -4211244 0 414262 523931 -109669 -109669 Shared services 900099 324000 324000 0 Other income 900099 153632 0 0 153632 477632 118392709 21124423 0 19930429 X 39568611 39568611 0 0 6227237 6227237 0 0 2603849 2109118 260385 234346 0 0 0 0 18010858 11777134 5394894 838830 661253 433835 190521 36897 1751554 1137880 522273 91401 1156591 751255 347112 58224 0 0 0 0 143217 91159 40123 11935 584883 372285 163858 48740 9500 9500 0 0 2905078 2905078 113023 0 113023 0 0 8185367 5720056 733331 1731980 8888362 5154323 173490 3560549 2212570 1712425 350285 149860 0 0 0 0 1055064 693021 305007 57036 1592123 1045854 439228 107041 0 0 0 0 1117210 612794 480230 24186 0 0 0 0 0 0 0 0 628212 377574 224247 26391 285184 182276 79888 23020 CONSULTING & PROF. SVCS. 11802868 10555127 1247741 EVENT PRODUCTION 2671287 2196147 243743 231397 BANK FEES 1514562 1029722 118546 366294 EQUIP. RENTAL & MAINT. 1226123 496283 444666 285174 5449636 5158245 186114 105277 120364222 97411861 12058705 10893656 X 32228489 19174880 2483225 10570384 0 0 12278347 66156825 30072080 28183942 446048 464293 0 0 0 0 0 0 259648 292557 1185467 2602199 9516747 7115605 943355 2401142 217483471 122241945 20021804 17941273 0 0 0 0 25800 25800 282716020 240309976 12764711 11874887 142210195 112186111 745442 587855 0 0 0 0 0 0 0 0 0 0 0 0 155720348 124648853 X 94533979 84147622 32136693 31188501 325000 325000 126995672 115661123 282716020 240309976 X -1971513 -16544067 -21104 7202135 X false true X true false X 174658160 159779664 118656952 91606572 77337857 622039205 0 0 0 0 0 0 0 0 174658160 159779664 118656952 91606572 77337857 622039205 8917603 613121602 3812083 4528150 4810808 4064746 3542123 20757910 0 0 0 0 84038 378313 351342 436740 153632 1404065 644201180 161403729 0.95176 0.95934 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 1500 52478 8000 39456 9500 91934 108296017 227949177 108305517 228041111 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 656218 144834 98255 91934 991241 250000 250000 250000 250000 1000000 1500000 519831 83839 68694 52478 724842 Lobbying Expenses Schedule C, Part II-A Public policy initiatives have the potential to impact people touched by BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO ELIMINATE BREAST CANCER AS A MAJOR HEALTH PROBLEM. 1346267 4717 4263 1346721 1325000 0 23736 2469 1346267 1325000 0 21 0 21 1325000 1225000 100000 33 0 33 1325000 1225000 608 0 608 1225000 0.75000 0.25000 0.00000 false false 0 0 0 0 0 0 0 0 610067 22596 587471 0 2488661 2283360 205301 0 6418019 4809649 1608370 2401142 Long/Short Equity Fund 17941273 F 17941273 0 0 X Intended use of endowment funds SCHEDULE D, PART V, LINE 4 KOMEN HAS THREE PERMANENT ENDOWMENTS: GOODMAN-BRINKER, FIRNBERG, AND A GENERAL ENDOWMENT. THE GOODMAN-BRINKER ENDOWMENT IS FOR BREAST CANCER RESEARCH FELLOWSHIPS; THE FIRNBERG ENDOWMENT IS FOR BREAST CANCER EDUCATIONAL PROGRAMS AND RESEARCH AWARDS; AND THE GENERAL ENDOWMENT'S EARNINGS ARE RESTRICTED FOR ORGANIZATIONAL MISSION ACTIVITIES. FIN 48 (ASC 740) FINANCIAL STATEMENT DISCLOSURE SCHEDULE D, PART X, LINE 2 THE ORGANIZATION IS SUBJECT TO A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WERE NO UNCERTAIN TAX POSITIONS RECORDED IN THE CONSOLIDATED FINANCIAL STATEMENTS AT MARCH 31, 2015 OR MARCH 31, 2014. true Central America and the Caribbean Grantmaking Education Grants 217718 Central America and the Caribbean Grantmaking Research Grants 109010 East Asia and the Pacific Grantmaking Research Grants 450249 Europe (Including Iceland and Greenland) Grantmaking Education Grants 533779 Europe (Including Iceland and Greenland) Grantmaking Research Grants 1747637 Middle East and North Africa Grantmaking Education Grants 401880 Middle East and North Africa Grantmaking Research Grants 435000 North America Grantmaking Education Grants 70000 North America Grantmaking Research Grants 1817751 South America Grantmaking Education Grants 327265 South America Grantmaking Research Grants 81948 Sub-Saharan Africa Grantmaking Education Grants 35000 Central America and the Caribbean 1 Investments Program support svcs 5378 South America 3 Program services Program support svcs 98027 North America 3 Program services Educ & Event Support 56500 East Asia and the Pacific 1 Program services Educ & Event Support 62428 Europe (Including Iceland and Greenland) 1 Program services Educ & Event Support 2979 Middle East and North Africa 3 Program services Educ & Event Support 17630 9 3 12 6452549 17630 6470179 Middle East and North Africa EDUCATION 104700 WIRE TRANSFR South America EDUCATION 104000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 405000 WIRE TRANSFR Middle East and North Africa Education 100000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 158022 WIRE TRANSFR North America RESEARCH 260000 WIRE TRANSFR South America Education 109920 WIRE TRANSFR Middle East and North Africa RESEARCH 435000 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION 77499 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION 9000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 16000 WIRE TRANSFR Europe (Including Iceland and Greenland) Education 42437 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 40000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 200000 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 149991 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 150000 WIRE TRANSFR North America Education 50000 WIRE TRANSFR Europe (Including Iceland and Greenland) Education 7500 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION 22343 WIRE TRANSFR Central America and the Caribbean EDUCATION 84618 WIRE TRANSFR Central America and the Caribbean Research 109010 WIRE TRANSFR South America EDUCATION 23345 WIRE TRANSFR South America Research 40000 WIRE TRANSFR South America EDUCATION 15000 WIRE TRANSFR North America Research 304598 WIRE TRANSFR North America EDUCATION 20000 WIRE TRANSFR Middle East and North Africa EDUCATION 50000 WIRE TRANSFR North America Research 29285 WIRE TRANSFR Europe (Including Iceland and Greenland) Research 175000 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 138623 WIRE TRANSFR Europe (Including Iceland and Greenland) Education 75000 WIRE TRANSFR North America Research 709128 WIRE TRANSFR Central America and the Caribbean EDUCATION 114400 WIRE TRANSFR Central America and the Caribbean EDUCATION 18700 WIRE TRANSFR Middle East and North Africa EDUCATION 45180 WIRE TRANSFR East Asia and the Pacific RESEARCH 150322 WIRE TRANSFR North America Research 224500 WIRE TRANSFR Europe (Including Iceland and Greenland) RESEARCH 315000 WIRE TRANSFR South America Education 75000 WIRE TRANSFR Middle East and North Africa EDUCATION 35000 WIRE TRANSFR Middle East and North Africa EDUCATION 72000 WIRE TRANSFR Middle East and North Africa EDUCATION 25000 WIRE TRANSFR East Asia and the Pacific Research 299927 WIRE TRANSFR Europe (Including Iceland and Greenland) Education 50000 WIRE TRANSFR North America Research 40060 WIRE TRANSFR North America RESEARCH 250180 WIRE TRANSFR South America Research 41948 WIRE TRANSFR Europe (Including Iceland and Greenland) EDUCATION 250000 WIRE TRANSFR 48 0 false false false false false false PROCEDURES FOR MONITORING USE OF GRANT FUNDS OUTSIDE OF THE UNITED STATES SCHEDULE F, PART I, LINE 2 As outlined in the grant agreement, all research, education, screening, and treatment grantees are required to submit, at a minimum, annual financial and progress reports and any change requests they may have for their projects. All progress reports and requests are reviewed by qualified staff. See Schedule I, Part IV for more details. X X X X X true Merkle Inc Direct Marketing false 15591036 2401859 13189177 EVENT 360 fundraising consulting false 23455909 154184 23301725 RADARWORKS fundraising consulting false 1008269 10365 997904 SLINGSHOT fundraising consulting false 0 196194 0 SOCIAL CAPITAL fundraising consulting false 0 107460 0 UNITED ENTERTAINMENT GROUP fundraising consulting false 0 35016 0 40055214 2905078 37488806 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY BRST CANCR 3DY 24144623 23505345 639278 1416 1125850 865784 4176 2815826 GBL RACE FR CUR 1842637 1292293 550344 16429 66411 26060 0 154031 3 2963209 2901864 61345 0 1882 103171 218651 11727 50797 28950469 27699502 1250967 0 19727 1295432 1110495 15903 3020654 5462211 -4211244 Schedule G Part II Net Income Summary GROSS RECEIPTS ARE REDUCED BY THE AMOUNT OF CONTRIBUTIONS, PER IRS INSTRUCTIONS. THE CONTRIBUTIONS FOR FISCAL YEAR 2015 WERE $26.5 MILLION. true Adventist Healthcare Inc 1801 Research Blvd Suite 300 Rockville MD 20850 521532556 501(C)(3) 229250 screening Alaska Native Tribal Health Consortium 4000 Ambassador Drive Anchorage AL 99508 920162721 501(C)(3) 62500 Screening Albert Einstein Col of Med Yeshiva Univ 1300 Morris Park AvenueBelfer 1108 Bronx NY 104611975 131624225 501(C)(3) 210001 Research Alexandria Neighborhood Health Services 2445 Army Navy Dr Arlington VA 22206 541849891 501(C)(3) 40240 Education, screening, & treatment American Association for Cancer Research 615 Chestnut Street 17th Fl Philadelphia PA 191064404 236251649 501(C)(3) 761000 research American Association on Health & Disability 110 N Washington StreetSuite 328J Rockville MD 20850 521884887 501(C)(3) 124999 education American Jewish Joint 711 Third Avenue New York NY 100174014 131656634 501(C)(3) 248594 education Arlington Free Clinic 2921 11th Street South Arlington VA 22204 541671883 501(C)(3) 118100 Education, Screening, and Treatment Baylor College Medicine One Baylor Plaza Houston TX 770303411 741613878 501(C)(3) 3475730 Research Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston MA 02215 042103881 501(C)(3) 441997 Research Bioethics International 420 Lexington Avenue New York NY 10170 870774767 501(C)(3) 15000 Education Boise State University 1910 University Dr Boise ID 837251247 826010706 501(C)(3) 40000 Research Boston University School of Medicine 580 Harrison Avenue 3-W Boston MA 02118 042103547 501(C)(3) 21204 Research Brigham and Women's Hospital PO Box 3149 Boston MA 022413149 042312909 501(C)(3) 362234 Research California Pacific Medical Center 475 Brannan Street Suite 220 San Francisco CA 94107 940562680 501(C)(3) 31818 Research Cancer Care 275 Seventh Ave New York NY 10001 131825919 501(C)(3) 41667 Treatment Capital City Area Health Education Center 1700 East Capitol St NE Suite E12 Washington DC 20003 263301051 501(C)(3) 100000 Education CASA of Maryland Inc 8151 15th Avenue Hyattsville MD 20783 521372972 501(C)(3) 35382 Education Case Western Reserve University 10900 Euclid Ave Cleveland OH 441067006 341018992 501(C)(3) 256915 Research Cincinnati Children's Hospital Medical 3333 Burnet Ave ML 7030 Cincinnati OH 45229 310833936 501(C)(3) 150000 Research Cold Spring Harbor Laboratory 1 Bungtown Rd Cold Spring Harbor NY 11724 112013303 501(C)(3) 254107 Research Columbia University Medical Center 615 W 131st St Studebaker 3rd Flr New York NY 10027 135598093 501(C)(3) 60000 Research Cornell University 341 Pine Tree Road Ithaca NE 14850 150532082 501(C)(3) 11797 Research Dana Farber Cancer Institute 44 Binney Street Mail Stop 439C Boston MA 02115 042263040 501(C)(3) 3011119 research Doctors Community Hospital 8116 Good Luck Rd 215 Lanham MD 207063502 521638026 501(C)(3) 375000 Education, Screening, and Treatment Dr Susan Love Research Foundation 2811 Wilshire Blvd Santa Monica CA 90403 770009065 501(C)(3) 40000 Research Duke University Medical Center 324 Blackwell St 1000 Durham NC 27701 560532129 501(C)(3) 2796277 Research Emory University Winship Cancer Inst PO Box 935084 Atlanta GA 311935084 580566256 501(C)(3) 401641 Research Ethiopian Community Development Council 901 S Highland Street Arlington VA 22204 521308986 501(C)(3) 227206 Education Facing Our Risk of Cancer Empowered 16057 Tampa Palms Blvd W 373 Tampa FL 33647 042103580 501(C)(3) 50000 Education Fox Chase Cancer Center 333 Cottman Avenue Philadelphia PA 19111 232003072 501(C)(3) 421468 Research Fred Hutchinson Cancer Research Center PO Box 19024 MS J6-330 Seattle WA 981091024 237156071 501(C)(3) 531775 research Friends of Cancer Research 1800 M St NW Washington DC 20036 521983273 501(C)(3) 40000 Research George Mason University 4400 University Drive MSN 4C6 Fairfax VA 22030 530196584 501(C)(3) 201940 Research George Washington University 2300 Eye St 514 Washington DC 200520011 530196584 501(C)(3) 166667 Education, Screening, and Treatment Georgetown University Box 571164 Washington DC 200571164 530196603 501(C)(3) 128687 Research Georgia Health Sciences Univ Rsrch Inst 1120 15th St CJ-3301 Augusta GA 30912 581418202 501(C)(3) 135811 Research Greater Baden Medical Services Inc 7450 Albert Rd 3-321 Brandywine MD 20316 520961414 501(C)(3) 99923 Screening & Treatment Harvard Medical School Holyoke Ctr Room 600 Cambridge MA 02138 042103580 501(C)(3) 99892 Research Harvard University 25 Shattuck St Boston MA 02115 042103580 501(C)(3) 265000 research Indiana University (Indianapolis) PO Box 66057 Indianapolis IN 462666057 356001673 501(C)(3) 5169633 Research International Scholarship & Tuition Services 1321 Murfreesboro Rd Nashville TN 37217 042697983 501(C)(3) 65000 Education Johns Hopkins University 1101 E 33rd St C210 Baltimore MD 21218 520595110 501(C)(3) 1657397 Research Karmanos Cancer Institute 4100 John R VE01FS Detroit MI 48201 131924236 501(C)(3) 41560 Research Korean Community Svc Ctr of Greater WA 7700 Little River Turnpike 406 Annandale VA 22003 386005984 501(C)(3) 163800 Screening Lawrence Berkeley National Laboratory PO Box 528 Berkeley CA 94701 942951741 501(C)(3) 47836 Research Leland Stanford Jr University 3145 Porter Drive Palo Alto CA 94304 941156365 501(C)(3) 1052968 Research Living Beyond Breast Cancer 354 W Lancaster Ave Haverford PA 19041 530196932 501(C)(3) 103000 Education Lutheran Hospital Association of 106 Blanca Ave Alamosa CO 81101 840255530 501(C)(3) 61692 screening Maasai Wildernes Conservation Fund PO Box 1413 Santa Barbara CA 93102 541943145 501(C)(3) 45360 Education Maryland Dept of Health & Mental Hygien 201 W Preston StRm 303 Baltimore MD 21201 526002033 501(C)(3) 62425 Screening Mary's Ctr for Maternal Child Care Inc 2333 Ontario Road NW Washington DC 20009 521594116 501(C)(3) 100000 Education Massachusetts General Hospital PO Box 414876 Boston MA 022414876 042697983 501(C)(3) 691352 Research Mayo Clinic and Foundation 4500 San Pablo Road Jacksonville FL 32224 541806317 501(C)(3) 181630 Research Mayo Clinic Rochester 200 1st St SW Rochester MN 55905 416011702 501(C)(3) 151799 Research Memorial Sloan-Kettering Cancer Ctr 633 3rd Ave 28th fl New York NY 10017 131924236 501(C)(3) 696111 Research Metastatic Breast Cancer Network 211 E 18th St New York City NY 10003 800418281 501(C)(3) 25000 Education Michigan State University 301 Admin Bldg East Lansing MI 48824 386005984 501(C)(3) 150000 Research Mobile Medical Care Inc 9309 Old Georgetown Rd Bethesda MD 208141620 237022588 501(C)(3) 147081 Education Mount Sinai School of Medicine 633 Third Avenue New York NY 10017 136171197 501(C)(3) 571384 Research Muslim Community Center Medical Clinic 15200 Newhampshire Ave Silver Spring MD 209055631 521072792 501(C)(3) 93971 Education, Screening, and Treatment New York University School of Medicine One Park Ave 11th Fl New York NY 10016 135562308 501(C)(3) 600000 Research Northwestern University 633 Clark Evanston IL 60208 362167817 501(C)(3) 631021 Research/Screening Nueva Vida Inc 2000 P St NW 300 Washington DC 20036 541943145 501(C)(3) 138523 Education, Screening, and Treatment Oklahoma Medical Research Foundation 825 NE 13th St Oklahoma City OK 73104 141368361 501(C)(3) 114904 Research Oncology Nursing Society 125 Enterprise Dr Pittsburgh PA 152751214 251410081 501(C)(3) 9453 Education Oregon Health & Science University 0690 SW Bancroft Portland OR 97239 752668014 501(C)(3) 328333 Screening/Research Partners for Cancer Care and Prevention 10 E Lee StUnit 1901 Baltimore MD 21202 451605551 501(C)(3) 25000 Education Patient Advocate Foundation 421 Butler Farm Rd Hampton VA 23666 830292601 501(C)(3) 750000 Treatment Pennsylvania State University MCG230 PO Box 850 Hershey PA 17033 246000376 501(C)(3) 1585543 Research Prevent Cancer Foundation 1600 Duke Street Alexandria VA 22209 521429544 501(C)(3) 67794 Education/Screening Primary Care Coalition-MontgomeryCty Inc 8757 Georgia Ave 10th Fl Silver Spring MD 20910 521847976 501(C)(3) 250000 Screening/Treatment Prince William Hospital 8700 Sudley Road Manassas VA 20110 541307595 501(C)(3) 46559 Education/Screening Princeton University 701 Carnegie Center Princeton NJ 08540 210634501 501(C)(3) 205000 Research Program for Appropriate PO Box 900922 Seattle WA 98109 911157127 501(C)(3) 190746 education Providence Health Foundation 1150 Varnum St NE Washington DC 20017 521275583 501(C)(3) 250000 screening Providence Portland Medical Center 4805 NE Glisan St 5F40 Portland OR 97213 930386906 501(C)(3) 120000 research Regents of University of Michigan Rm 7110 CCGCIntnl Med Ann Arbor MI 48109 746000949 501(C)(3) 60000 Research Research Advocacy Network 6505 W Park Blvd Plano TX 75093 566001393 501(C)(3) 56104 Research Roswell Park Alliance Foundation Dept of Immunology Buffalo NY 14263 161391608 501(C)(3) 419982 Research Smith Farm Center for Healing & the Arts 1632 U St NW Washington DC 20009 590624458 501(C)(3) 166667 Education, Screening, and Treatment Society for Surgical Oncology 85 W Algonquin Rd Arlington Heights IL 60005 136161070 501(C)(3) 54000 Research Society for Women's Health Research 1025 CT Ave NW Washington DC 20036 956006144 501(C)(3) 264487 Research South East Alaska 3245 Hospital Drive Juneau AK 99801 920056274 501(C)(3) 21250 Screening Stanford University PO Box 44253 San Francisco CA 941444253 941156365 501(C)(3) 23366 Research The Alliance of Pennsylvania Councils 3461 Market Street Camp Hill PA 17011 251888581 501(C)(3) 106816 Screening The General Hospital Corporation 101 Huntington Ave 300 Boston MA 02199 042697983 501(C)(3) 91966 Research The James Ewing Foundation 520 Green Bay Rd Winnetka IL 60093 112498503 501(C)(3) 57500 Research The Red Devils PO Box 36291 Towson MD 21286 743070929 501(C)(3) 11595 Treatment The Salk Institute 10010 N Torrey Pines Rd La Jolla CA 920371002 376000511 501(C)(3) 360000 Research The University of Chicago 5801 S Ellis Ave Chicago IL 60637 362177139 501(C)(3) 752761 Research The Wistar Institute 3601 Spruce St Philadelphia PA 191044265 236434390 501(C)(3) 96220 Research Univ of Colorado Health Sciences Center Grants and Contracts Denver CO 802910238 846000555 501(C)(3) 78628 Research Univ of North Carolina at Chapel Hill 104 Airport Dr 2200 Chapel Hill NC 275991350 566001393 501(C)(3) 813876 education/Research Univ of Texas MD Anderson Cancer Center 1515 Holcombe Blvd 1644 Houston TX 770304009 746001118 501(C)(3) 5663361 Research University of Miami School of Medicine 1400 NW 10th Ave Miami FL 33136 590624458 501(C)(3) 341931 Research University of Alabama at Birmingham 1720 2nd Ave S Birmingham AL 35294 636005396 501(C)(3) 1430490 Research University of Arizona PO Box 44390 Tucson AZ 857334390 742652689 501(C)(3) 150000 Research University of California at San Diego 9500 Gilman Dr MC 0009 La Jolla CA 92093 956006144 501(C)(3) 120096 Research University of California at San Francisco 3333 Calif St 315 San Francisco CA 94107 946036493 501(C)(3) 1147167 research University of California at Santa Cruz 1156 High St Santa Cruz CA 95064 941539563 501(C)(3) 58562 Research University of California-Berkeley 2195 Hearst Ave Rm 130 Berkeley CA 947201103 946002123 501(C)(3) 11659 Research University of California-Los Angeles 10920 Wilshire Blvd 107 Los Angeles CA 900246503 956006143 501(C)(3) 360000 research University of Central Florida 12424 Research Pkwy 300 Orlando FL 328283249 592924021 501(C)(3) 39991 Research University of Cincinnati PO Box 210222 Cincinnati OH 452210222 316000989 501(C)(3) 565831 Research University of Delaware 30 Lovett Ave Newark DE 19716 516000279 501(C)(3) 15823 research University of Illinois at Chicago PO Box 20787 Springfield IL 627080787 376000511 501(C)(3) 290542 Research University of Kansas Center for Research 2385 Irving Hill Road Lawrence KS 66045 480680117 501(C)(3) 60000 Research University of Kansas Medical Center 3901 Rainbow Bld MSN 1039 Kansas City KS 66160 481108830 501(C)(3) 2790541 Research University of Maryland-Baltimore PO Box 41428 Baltimore MD 202036428 526002033 501(C)(3) 69999 Research University of Michigan 3086 Wolverine Tower Ann Arbor MI 481091274 386006309 501(C)(3) 2498286 Research University of Minnesota 200 Oak St SE 450 Minneapolis MN 554552070 416007513 501(C)(3) 728842 Research University of Mississippi Medical Center 2500 N State St Jackson MS 39216 646008520 501(C)(3) 198713 Research University of Nebraska 985100 Nebraska Med Ctr Omaha NE 681985100 470049123 501(C)(3) 12000 research University of Notre Dame du Lac 731 Grace Hall Notre Dame IL 46556 350868188 501(C)(3) 150000 research University of Pennsylvania 3451 Walnut St P-211 Franklin Bldg Philadelphia PA 191046205 231352685 501(C)(3) 548650 research University of Pittsburgh 350 Thackeray Hall Pittsburgh PA 15260 250966691 501(C)(3) 733000 research University of South Dakota 2301 E 60th St N Sioux Falls SD 57104 466000364 501(C)(3) 40031 research University of Southern California Univ Gardens Bldg Los Angeles CA 900898001 951642394 501(C)(3) 150000 research University of Tennessee 1926 Alcoa Hwy 342 Knoxville TN 37920 311626179 501(C)(3) 36904 Research University of TX at Hlth Science Ctr 7703 Floyd Curl Dr MSC 7828 San Antonio TX 782293900 741586031 501(C)(3) 321966 Research University of Utah 201 S Pred Crcl 406 Salt Lake City UT 841129020 976000525 501(C)(3) 60000 Research University of Washington 3917 Univ Way NE Seattle WA 98105 916001537 501(C)(3) 792237 research University of Wisconsin Hospital 21 N Pk St 6401 Madison WI 537151218 396006492 501(C)(3) 129670 research UT HSC - San Antonio 7703 Floyd Curl Dr San Antonio TX 772293900 746002868 501(C)(3) 680000 Research UT Southwestern Medical Center at Dallas PO Box 841753 Dallas TX 752841753 746002868 501(C)(3) 76181 research Vaccine & Gene Therapy Institute of Fla 9801 SW Discovery Way Port St Lucie FL 34987 364631835 501(C)(3) 180596 research Vanderbilt University Medical Center 3319 W End Ave 100 Nashville TN 37203 620476822 501(C)(3) 1259252 research Vietnamese Resettlement Association Inc 6131 Willston Dr Rm 6 Falls Church VA 22044 541512549 501(C)(3) 46559 Education, Screening, and Treatment Virginia Commonwealth University PO Box 843039 Richmond VA 232843038 546001758 501(C)(3) 360000 research Wake Forest University Health Sciences Medical Center Blvd WinstonSalem NC 27157 223849199 501(C)(3) 160000 research Washington University at St Louis 700 Rosedale Ave Box 1034 St Louis MO 63112 430653611 501(C)(3) 3877704 Research & SCREENING Wayne State University 5057 Woodward Ave 13th Fl Detroit MI 48202 366028429 501(C)(3) 502268 research West Virginia University 886 Chestnut Ridge Rd Morgantown WV 265066845 550665758 501(C)(3) 30000 research Widener University One University Place Chester PA 19013 231386178 501(C)(3) 120000 research Winchester Medical Center Foundation 1840 Amherst Street Winchester VA 22601 542013319 501(C)(3) 68567 screening Yale University School of Medicine 47 College Street New Haven CT 065103209 060646973 501(C)(3) 40000 research Young Survival Coalition Lori Atkinson New York NY 10006 134057685 501(C)(3) 40000 education 138 0 Procedures for Monitoring the Use of Grants SCHEDULE I, PART I, LINE 2 SUSAN G. KOMEN'S (KOMEN) POLICIES FOR MANAGING RESEARCH, EDUCATION, SCREENING, AND TREATMENT GRANTS FROM THE TIME OF INITIAL AWARD THROUGH COMPLETION SEEK TO MAXIMIZE FLEXIBILITY WHILE MAINTAINING THE HIGHEST STANDARD OF ACCOUNTABILITY AND PRESERVING THE INTEGRITY OF THE REVIEW AND FUNDING PROCESS. FOR RESEARCH GRANTS, SCIENTIFIC PROGRESS IS MONITORED THROUGHOUT THE GRANT TERM BY A PH.D.-LEVEL SCIENTIFIC GRANTS MANAGER. THE GRANTEE IS REQUIRED TO SUBMIT SCIENTIFIC PROGRESS REPORTS ON EACH ANNIVERSARY OF THE GRANT START DATE FOR THE DURATION OF THE PROJECT, EXCEPT FOR THE FINAL YEAR OF THE GRANT WHEN A FINAL REPORT IS DUE NO LATER THAN 30 DAYS AFTER THE END DATE OF THE GRANT TERM. A SCIENTIFIC PROGRESS REPORT ALSO IS DUE IF THE GRANTEE IS REQUESTING AN EXTENSION TO THE END OF THE GRANT TERM OR ACCELERATION OF THE GRANT TERM. THE GRANTEE MUST SUBMIT REQUESTS FOR ANY CHANGES TO THE DESIGN OF THE FUNDED RESEARCH PROJECT, OR CHANGES TO KEY PERSONNEL AND THEIR LEVEL OF EFFORT FOR KOMEN'S APPROVAL PRIOR TO IMPLEMENTING SAID CHANGES. ALL GRANT FUNDS MUST BE EXPENDED IN ACCORDANCE WITH THE PROJECT'S APPROVED BUDGET, AND ARE DISBURSED IN ACCORDANCE WITH THE SCHEDULE DOCUMENTED WITHIN THE GRANT AGREEMENT. ANNUAL FINANCIAL REPORTS ARE DUE NO LATER THAN 30 DAYS AFTER EACH ANNIVERSARY OF THE GRANT START DATE FOR THE DURATION OF THE GRANT TERM, WITH THE EXCEPTION OF THE FINAL FINANCIAL REPORT, WHICH IS DUE NO LATER THAN 60 DAYS AFTER THE END DATE OF THE GRANT TERM. ALL EXPENDITURES MUST BE REPORTED IN UNITED STATES DOLLARS ($USD). THE GRANTEE MUST SUBMIT A REQUEST FOR A BUDGET CHANGE IN THE EVENT THE GRANTEE WISHES TO MOVE FUNDS ACROSS BUDGET CATEGORIES IN EXCESS OF THE ALLOWABLE LIMITS AS STATED WITHIN THE POLICIES AND PROCEDURES. UPON TERMINATION OF A GRANT, UNEXPENDED FUNDS MUST BE REMITTED 30 DAYS AFTER RECEIPT OF AN INVOICE FROM KOMEN. WITH REASONABLE PRIOR NOTICE TO THE GRANTEE, KOMEN MAY REQUIRE ADDITIONAL PROGRESS AND/OR FINANCIAL REPORTING FROM THE GRANTEE AND ALSO MAY REQUIRE THE GRANTEE TO PARTICIPATE IN SITE VISITS, TELEPHONE CONFERENCES, PRESENTATIONS, OR OTHER SPEAKING ENGAGEMENTS. AS PART OF ITS OVERSIGHT OF RESEARCH PROGRESS, KOMEN MAY ADJUST THE PROJECT REPORTING PERIOD AND ASSOCIATED DISBURSEMENT OF GRANT FUNDS AT ANY TIME DURING THE GRANT TERM WITH PRIOR WRITTEN NOTICE TO THE GRANTEE. KOMEN WILL NOT BE RESPONSIBLE FOR A) ANY EXPENDITURE MADE PRIOR TO THE EFFECTIVE DATE OR AFTER THE TERMINATION OF THE GRANT, B) COMMITMENTS MADE DURING THE GRANT TERM BUT NOT PAID WITHIN SIXTY (60) DAYS FOLLOWING THE EXPIRATION OF THE GRANT AGREEMENT, C) EXPENDITURES THAT ARE NOT PERMITTED AS DESCRIBED WITHIN THE RFA, OR D) ANY EXPENDITURE THAT IS INCONSISTENT WITH THE APPROVED RESEARCH PLAN AND BUDGET OR THAT EXCEEDS THE TOTAL AMOUNT OF THE GRANT. KOMEN HAS THE RIGHT TO CONDUCT AN AUDIT OF THE RECORDS RELATED TO A GRANT AT ANY TIME DURING THE GRANT AND FOR FIVE YEARS THEREAFTER. KOMEN'S POLICIES FOR MANAGING EDUCATION, SCREENING, AND TREATMENT GRANTS REQUIRE THAT ALL GRANTEES SIGN A GRANT AGREEMENT, WHICH SETS FORTH THE TERMS OF THE GRANT, INCLUDING THE PURPOSE OF THE GRANT, AMOUNT, BUDGETARY RESTRICTIONS, DURATION, PAYMENT SCHEDULE, REPORTING REQUIREMENTS, AND AUDIT AND EARLY TERMINATION RIGHTS FOR KOMEN. PROGRESS IS MONITORED THROUGHOUT THE GRANT TERM BY A COMMUNITY HEALTH GRANTS MANAGER. THE GRANTEE IS REQUIRED TO SUBMIT PROGRESS REPORTS (TYPICALLY EVERY SIX MONTHS) THAT DETAIL PROGRESS TOWARD MEETING EACH OF THE OBJECTIVES AND ANY CHALLENGES ENCOUNTERED. THE PROGRESS REPORT MUST ALSO INCLUDE A FULL ACCOUNTING OF GRANT FUNDS EXPENDED (ACTUAL VERSUS BUDGETED EXPENSES). THE GRANTS MANAGER MAY CONDUCT SITE VISITS WITH THE GRANTEE, WHEN APPROPRIATE, TO BUILD A STRONGER RELATIONSHIP WITH THE GRANTEE; TO GAIN A BETTER UNDERSTANDING OF ITS WORK; AND TO ADDRESS ANY CHALLENGES OR PROBLEMS THE GRANTEE IS FACING. ANY CHANGES TO THE PROJECT MUST BE APPROVED BY KOMEN'S GRANTS MANAGER IN WRITING IN ADVANCE OF THE CHANGE. A FINAL REPORT MUST BE PROVIDED AT THE COMPLETION OR EARLY TERMINATION OF THE GRANT AND MUST INCLUDE, AMONG OTHER THINGS, A FINANCIAL REPORT AND AN EVALUATION OF THE PROGRAM'S ACCOMPLISHMENTS AND IMPACT IN THE COMMUNITY. Upon termination of the grant, any unexpended funds must be remitted to Komen unless otherwise directed. X true true X X X X X true false false false false false false false false Dr Judith Salerno President & CEO 474734 0 0 0 5124 0 0 0 3625 0 483483 0 0 0 Ellen Willmott Gen Counsel & Secretary 261354 0 0 0 2802 0 15345 0 9034 0 288535 0 0 0 Lesley Lurie Assistant Secretary 199164 0 0 0 2203 0 10603 0 16544 0 228514 0 0 0 Nancy G Brinker Board Member & Founder 389782 0 0 0 7311 0 15478 0 10014 0 422585 0 0 0 David Dawson VP, Information Technology 156262 0 0 0 333 0 8872 0 17250 0 182717 0 0 0 Kay Merrell VP, Human Resources 199488 0 5000 0 4513 0 10704 0 17824 0 237529 0 0 0 Miguel Perez VP Affiliate Ntwrk 181090 0 0 0 2769 0 10878 0 8325 0 203062 0 0 0 Wendy Carter Director, Global Outreach 168759 0 4950 0 2278 0 0 0 1269 0 177256 0 0 0 Andrea Rader Managing Director, Comm. 160433 0 0 0 3051 0 7694 0 13837 0 185015 0 0 0 Subhendu Rath Director, IT Enterprise System 148334 0 712 0 1817 0 9152 0 14537 0 174552 0 0 0 Stephanie Birkey Reffey PHD Managing Dir. Evaluation & Out 146266 0 0 0 5987 0 9227 0 19751 0 181231 0 0 0 Victoria Wolodzko Mng Director, Grants & PrOG AD 162996 0 0 0 2495 0 9798 0 7761 0 183050 0 0 0 Mark Nadolny Chief Finan Officer (END 9/14) 246694 0 0 0 46916 0 13868 0 14413 0 321891 0 0 0 Chandini Portteus CHIEF MISSION OFFCR (END 9/14) 220483 0 0 0 60555 0 13489 0 18231 0 312758 0 0 0 FORM 990, SCHEDULE J, PART I, LINE 1A SUPPLEMENTAL COMPENSATION INFORMATION FIRST CLASS AND BUSINESS CLASS FARES FOR DOMESTIC TRAVEL, CANADA, THE CARIBBEAN, CENTRAL AMERICA, AND MEXICO ARE NOT REIMBURSABLE. HOWEVER, PERSONAL FREQUENT FLIER MILEAGE AND/OR COUPONS MAY BE USED FOR NO-COST UPGRADES. Business or first class requires advance written approval as part of a medical accommodation or in the event of international travel with flight times of six hours or more, based on business need. WHENEVER POSSIBLE, DISCOUNTED FIRST CLASS AND UPGRADES ARE USED TO MINIMIZE COST. SCHEDULE J, PART I, LINE 4A DURING CALENDAR YEAR 2014 THE FOLLOWING SEVERANCE PAYMENTS WERE MADE: Mark Nadolny $41,717 Chandini Porteus $58,867 X 2920 Cost or sales price X 15000 39350 cost or sales price X Personal care packet 40000 30977 Cost or Sales Price 0 false true false Volunteers FORM 990, PART I, QUESTION 6 VOLUNTEERS SERVE IN A VARIETY OF WAYS, BUT THE GREATEST NUMBERS OF VOLUNTEERS ASSIST WITH THE SUSAN G. KOMEN 3 DAY SERIES. FORM 990, PART III - PROGRAM SERVICE ACCOMPLISHMENTS SUSAN G. KOMEN IS THE WORLD'S LARGEST BREAST CANCER ORGANIZATION, FUNDING MORE BREAST CANCER RESEARCH THAN ANY OTHER NONPROFIT WHILE PROVIDING REAL-TIME HELP TO THOSE FACING THE DISEASE. SINCE ITS FOUNDING IN 1982, KOMEN HAS FUNDED MORE THAN $889 MILLION IN RESEARCH AND PROVIDED $1.9 BILLION IN FUNDING TO SCREENING, DIAGNOSIS, TREATMENT, EDUCATION, HEALTH SYSTEMS IMPROVEMENT, AND PSYCHOSOCIAL SUPPORT PROGRAMS SERVING MILLIONS OF PEOPLE IN MORE THAN 30 COUNTRIES WORLDWIDE. KOMEN WAS FOUNDED BY NANCY G. BRINKER, WHO PROMISED HER SISTER, SUSAN G. KOMEN, THAT SHE WOULD END THE DISEASE THAT CLAIMED SUZY'S LIFE. A - Research SINCE ITS FOUNDING IN 1982, KOMEN'S RESEARCH INVESTMENTS HAVE CONTRIBUTED TO COUNTLESS MAJOR ADVANCES IN BREAST CANCER SCIENCE. IN JUST ONE GENERATION, THE PROGRESS HAS BEEN SIGNIFICANT - TODAY, WE KNOW THAT BREAST CANCER IS MORE THAN A SINGLE DISEASE. WE HAVE A BETTER UNDERSTANDING OF THE GENETICS OF BREAST CANCER AND THE CRITICAL NEED TO TAILOR SCREENING, DIAGNOSIS, TREATMENT AND PREVENTION STRATEGIES TO INDIVIDUALS THROUGH ADVANCES IN PRECISION MEDICINE. KOMEN'S RESEARCH PROGRAMS ARE DESIGNED TO UNDERSTAND THE BIOLOGY OF BREAST CANCER AND ADVANCE THE TRANSLATION OF RESEARCH DISCOVERIES INTO NEW WAYS TO DETECT, DIAGNOSE, TREAT, AND PREVENT BREAST CANCER, IN ORDER TO REDUCE BREAST CANCER INCIDENCE AND MORTALITY WITHIN THE NEXT DECADE. TO ENSURE MAXIMUM IMPACT, Komen calls on its Mission Advisors-the best and brightest breast cancer researchers, clinicians, advocates and other experts- to help guide and implement our mission programs. Thanks to their efforts, we're driving discovery, affecting change and accelerating progress in the fight against breast cancer. The Scientific Advisory Board (SAB) provides strategic guidance and direction for our research and scientific programs, and plays a key role in guiding and prioritizing Komen's global research investment. The SAB is led by the chief scientific advisors and serves as the executive committee of the Komen Scholars. The Komen Scholars are an advisory group of 60 distinguished leaders in breast cancer research and advocacy. Representing more than 32 institutions in seven countries, their expertise includes clinical research, laboratory research, pathology, prevention, radiation oncology, surgery and other disciplines and specialties. They contribute to our programs, activities and events in many ways-most notably by leading and participating as reviewers in our scientific peer review process - and act as our ambassadors in communities around the U.S. and the world. Komen's research advocates, Advocates In Science (AIS), bring the patient voice to research, ensuring that the unique and valuable perspectives of breast cancer patients, survivors, and co-survivors are integrated into the scientific dialogue and decisions that impact progress toward ending breast cancer. Komen uniquely includes AIS in every step of the research investment process: They serve on our Scientific Advisory Board and Komen Scholars; participate in research grant peer reviews; work with or as part of scientific teams to help prioritize, develop and implement research projects; and educate our Affiliates and the public to enhance community awareness, understanding, and support of breast cancer research. KOMEN RESEARCH AND TRAINING PROGRAM: KOMEN AWARDS GRANTS TO INDIVIDUAL SCIENTISTS, RESEARCH TEAMS AND ORGANIZATIONS AROUND THE WORLD THROUGH A TRANSPARENT AND RIGOROUS PEER REVIEW PROCESS THAT ENSURES MAXIMUM IMPACT FOR OUR RESEARCH DOLLARS. OUR SCIENTIFIC ADVISORY BOARD DETERMINES THE MOST CRITICAL AREAS OF NEED IN BREAST CANCER RESEARCH. THESE NEEDS DETERMINE THE AREAS OF RESEARCH FOCUS IN THE REQUEST FOR APPLICATIONS (RFA). THE RFA IS ANNOUNCED AND RESEARCHERS SUBMIT SHORT VERSIONS OF THEIR PROPOSALS, DESCRIBING BOTH THE PROPOSED STUDY AND POTENTIAL CLINICAL IMPACT OF THE PROJECT. THESE PRE-APPLICATIONS ARE SCIENTIFICALLY REVIEWED BY PEER-REVIEW COMMITTEES WHICH ARE LED BY A CHAIRPERSON AND COMPRISED OF OUR KOMEN SCHOLARS, ADVOCATES IN SCIENCE AND OTHER PROMINENT RESEARCHERS AND ADVOCATES FROM AROUND THE GLOBE. APPROXIMATELY 20-25 PERCENT OF THESE PRE-APPLICATIONS WILL BE IDENTIFIED AS THE MOST MERITORIOUS AND ALIGNED WITH OUR RESEARCH OBJECTIVES. UPON APPROVAL BY OUR SCIENTIFIC ADVISORY BOARD, APPLICANTS WILL BE INVITED TO SUBMIT FULL APPLICATIONS FOR FURTHER PEER REVIEW AND FUNDING CONSIDERATION. FULL APPLICATIONS ARE DISCUSSED, RATED AND SCORED BY THE ASSIGNED REVIEWERS - INCLUDING MEMBERS OF THE KOMEN SCHOLARS AND ADVOCATES IN SCIENCE- WHO ASSESS THE STRENGTHS AND WEAKNESSES OF EACH APPLICATION BASED ON DEFINED REVIEW CRITERIA SUCH AS SCIENTIFIC MERIT AND POTENTIAL FOR IMPACT. THE OVERALL SCORES FOR EACH APPLICATION ARE THEN USED BY THE SCIENTIFIC ADVISORY BOARD TO MAKE FINAL FUNDING RECOMMENDATIONS ACROSS ALL RESEARCH MECHANISMS. APPLICATIONS ARE RECOMMENDED FOR FUNDING IN THE ORDER OF THE OVERALL AVERAGE SCORE. THE SCIENTIFIC ADVISORY BOARD'S RECOMMENDATIONS ARE FORWARDED TO KOMEN LEADERSHIP, WHO APPROVE THE FINAL SLATE OF APPLICATIONS FOR FUNDING. THE BOARD OF DIRECTORS APPROVES THE ANNUAL BUDGET FOR KOMEN, WHICH INCLUDES THE TOTAL BUDGET FOR GRANTS. THE BOARD OF DIRECTORS HOLDS THE RESPONSIBILITY OF REVIEWING THE FINANCIAL HEALTH OF THE ORGANIZATION AND APPROVING ANY REDUCTIONS OR INCREASES IN THE TOTAL MISSION BUDGET FOR GRANTS. PEER-REVIEW IS A GRANT REVIEW PROCESS USED BY MANY ORGANIZATIONS, INCLUDING THE NATIONAL INSTITUTES OF HEALTH (NIH), TO DETERMINE WHICH RESEARCH GRANTS WILL BE FUNDED. IN FACT, THE NIH HAS DESIGNATED, PER PROGRAM ANNOUNCEMENT STANDARD NUMBER PAR-13-386, THAT KOMEN MAINTAINS A PEER REVIEW SYSTEM THAT IS FREE OF CONFLICTS OF INTEREST AND THAT BASES DECISIONS ON SCIENTIFIC MERIT. BY USING THIS RIGOROUS PROCESS, WE STRIVE TO FUND THE VERY BEST RESEARCH - FUNDING PROJECTS THAT HAVE THE POTENTIAL TO ADVANCE THE FIELD AND HAVE AN IMPACT ON PATIENTS AS RAPIDLY AS POSSIBLE. A TYPICAL PEER-REVIEW PROCESS CAN INVOLVE MORE THAN 400 SCIENTISTS AND ADVOCATE REVIEWERS AND UP TO 23 TO 25 PEER-REVIEW COMMITTEES. ALTHOUGH THE NUMBER OF APPLICATIONS RECEIVED VARIES FROM YEAR TO YEAR, KOMEN TYPICALLY RECEIVES BETWEEN 950 AND 1,050 PRE-APPLICATIONS ANNUALLY. FUNDING RATIOS CAN VARY CONSIDERABLY BY YEAR AND GRANT TYPE. IN FISCAL YEAR 2015, KOMEN AWARDED 124 GRANTS THROUGH ITS RESEARCH PROGRAMS TO SUPPORT SCIENTIFIC RESEARCH, COLLABORATIONS AND TRAINING IN THE UNITED STATES AND OTHER COUNTRIES, INCLUDING AUSTRALIA, BRAZIL, CANADA, ISRAEL, ITALY, JORDAN, MEXICO, PANAMA, SPAIN AND SWITZERLAND. WE CONSIDER IT OUR RESPONSIBILITY TO ENSURE THE CONTINUITY OF BREAST CANCER RESEARCH FOR THE FUTURE. WITH FEDERAL RESEARCH BUDGETS TIGHTENING, WE CANNOT AFFORD TO LOSE PROMISING YOUNG INVESTIGATORS FOR LACK OF FUNDING. TO THAT END, THE FOLLOWING REQUEST-FOR-APPLICATIONS (RFA) GRANT OPPORTUNITIES WERE OFFERED BY KOMEN DURING FISCAL YEAR 2015: POSTDOCTORAL FELLOWSHIPS (PDF): PDF GRANTS SEEK TO ATTRACT AND SUPPORT PROMISING SCIENTISTS EMBARKING ON CAREERS DEDICATED TO BREAST CANCER RESEARCH WHO HAVE NO MORE THAN 3 YEARS POST-COMPLETION OF THEIR MOST RECENT CLINICAL FELLOWSHIP, 5 YEARS POST-COMPLETION OF THEIR MOST RECENT RESIDENCY (FOR PHYSICIANS) OR 5 YEARS POST-COMPLETION OF THEIR MOST RECENT PHD. BY PROVIDING FUNDING TO OUTSTANDING POSTDOCTORAL/POSTGRADUATE FELLOWS UNDER THE GUIDANCE OF A MENTOR, KOMEN SEEKS TO ENSURE THAT A DIVERSE POOL OF HIGHLY TRAINED SCIENTISTS WILL EMERGE AS THE NEXT GENERATION OF LEADERS IN THE FIELD OF BREAST CANCER RESEARCH. PDF GRANTS PROVIDE SUPPORT FOR RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. GRADUATE TRAINING IN DISPARITIES RESEARCH (GTDR): GTDR GRANTS (FORMERLY POST-BACCALAUREATE TRAINING IN DISPARITIES RESEARCH GRANTS) ARE INTENDED TO ESTABLISH AND/OR TO SUSTAIN A TRAINING PROGRAM DEDICATED TO UNDERSTANDING AND ELIMINATING DISPARITIES IN BREAST CANCER OUTCOMES ACROSS POPULATION GROUPS. AT LEAST THREE GRADUATE STUDENTS, PREFERABLY THOSE from populations affected by disparities in breast cancer outcomes, ARE SUPPORTED. CAREER CATALYST RESEARCH (CCR): CCR GRANTS PROVIDE UNIQUE OPPORTUNITIES FOR SCIENTISTS WHO HAVE HELD FACULTY POSITIONS FOR NO MORE THAN SIX YEARS AT THE TIME OF FULL APPLICATION TO ACHIEVE RESEARCH INDEPENDENCE. CCR GRANTS PROVIDE SUPPORT FOR HYPOTHESIS-DRIVEN RESEARCH PROJECTS THAT HAVE SIGNIFICANT POTENTIAL TO ADVANCE OUR UNDERSTANDING OF BREAST CANCER, LEAD TO REDUCTIONS IN BREAST CANCER INCIDENCE AND/OR MORTALITY AND MOVE US TOWARD OUR GOAL OF A WORLD WITHOUT BREAST CANCER. KOMEN'S RESEARCH INVESTMENT THROUGH THE ABOVE GRANT MECHANISMS SUPPORT PROJECTS THAT AIM TO, Executive Committee FORM 990, PART VI, LINE 1A The Organization's Bylaws provide for an Executive Committee comprised of a minimum of five members including the Board Chair, the President and Chief Executive Officer, and additional Board members, as recommended by the Governance Committee and appointed by the Board of Directors. Members of the Executive Committee must either be Directors of the Organization or the President and Chief Executive Officer. The Bylaws provide that the Executive Committee has the power to (a) appoint members to non-standing committees of the Organization, and name chairs of such committees; (b) authorize unbudgeted disbursements by the Organization in accordance with the specific expenditure authority prescribed by the Board of Directors; (c) employ agents; and (d) carry into execution such other measures as it determines will promote the purpose of the Organization. The committee also may exercise, when the board is not in session, all of the authority of the board in the management of the business and affairs of the organization with certain exceptions such as repealing any board resolutions, amending the organization's articles or bylaws, or merging or dissolving the organization. This delegation does not relieve the board of any of its responsibilities imposed by law, and the committee endeavors to limit its exercise of authority to time sensitive issues. SIGNIFICANT CHANGES TO GOVERNING DOCUMENTS FORM 990, PART VI, QUESTION 4 SIGNIFICANT CHANGES during fiscal year 2015: - Established the minimum/maximum number of directorships at 7/13 - Established a minimum/maximum total for Class III directors (minimum of two and a maximum of three) and Class IV directors (minimum of 3 and maximum of 9), but never more than 13 total - Increased term limits for (a) Class III directors to a single 3-year term and (b) Class IV directors to two consecutive 3-year terms - Allowed for Class III and IV directors to take a leave of absence for no more than 6 months and allowed for the board to appoint an interim Class IV director during the period of the leave of any director - Recognized that the chair will act as the tiebreaking vote in the event of a deadlock in a board vote - Clarified that filling a vacancy on the board is not counted as a term - Clarified that, for Class IV directors, a second term is possible but not assured - Clarified the parameters and term limits associated with board election of directors to fill vacant directorships between annual meetings - Revised the committee terms for appointment of director members (annually appointed) and non-director members (biennially appointed) and clarified that committee appointments take place at the annual meeting - Clarified that there are both voting and non-voting ex officio appointments to committees - Added a Class III director to those board members required to serve on the Executive Committee (also allowed for the discretional appointment of Class IV director(s) to the Executive Committee) - Permitted the President & CEO to appoint non-director officers without an amendment to the Bylaws DESCRIBE THE PROCESS USED BY MANAGEMENT &/OR GOVERNING BODY TO REVIEW 990 FORM 990, PART VI, QUESTION 11B MANAGEMENT PREPARES THE MATERIALS FOR THE FORM 990, WITH THE ASSISTANCE OF AND REVIEW BY EXTERNAL ACCOUNTANTS. SENIOR LEVELS OF MANAGEMENT REVIEW AND COMMENT ON THE FINAL DRAFT OF THE FORM 990 FOR PRESENTATION TO THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS REVIEWS AND MAKES AN APPROVAL RECOMMENDATION REGARDING THE FORM 990 TO THE BOARD OF DIRECTORS. THEREAFTER, THE BOARD OF DIRECTORS APPROVES THE FORM 990 PRIOR TO THE FORM BEING FILED. DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICTS OF INTEREST FORM 990, PART VI, QUESTION 12C KOMEN PRODUCES AN ANNUAL SURVEY REQUIRING ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS, AND ADVISORY BOARDS TO DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICTS OF INTEREST THEY MAY HAVE. ANY CONFLICTS ARE THEN REVIEWED BY MANAGEMENT AND THE AUDIT COMMITTEE AND APPROPRIATE MEASURES ARE TAKEN. ALL EMPLOYEES, BOARD MEMBERS, COMMITTEE MEMBERS AND ADVISORY BOARDS ARE REQUIRED TO UPDATE THEIR CONFLICT OF INTEREST DISCLOSURES AS NECESSARY DURING THE YEAR. OFFICES & POSITIONS FOR WHICH PROCESS WAS USED, & YEAR PROCESS WAS BEGUN FORM 990, PART VI, QUESTIONS 15A AND 15B THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS ASSISTS THE BOARD IN OVERSEEING COMPENSATION POLICIES AND PRACTICES. RESPONSIBILITIES INCLUDE OVERSIGHT OF THE COMPENSATION OF THE PRESIDENT/CHIEF EXECUTIVE OFFICER, THE RANGE OF COMPENSATION LEVELS FOR THE ORGANIZATION'S OTHER OFFICERS, DISQUALIFIED PERSONS, AND OTHER EMPLOYEES, GRANTING THE CEO AUTHORITY TO DETERMINE ACTUAL COMPENSATION LEVELS WITHIN AN APPROVED RANGE, AND INCENTIVE/BONUS COMPENSATION PROGRAMS, IF APPROVED. THE CURRENT POLICY WAS ADOPTED IN 2010. A FORMAL COMPENSATION POLICY GOVERNS PAY PRACTICES. PERIODICALLY, ALL POSITIONS IN THE ORGANIZATION ARE REVIEWED AGAINST EXTERNAL MARKET DATA BY ENGAGING INDEPENDENT EXPERTS OR ACQUIRING UPDATED MARKET DATA TO CONDUCT THE BENCHMARKING PROCESS. COMPENSATION IS THEN BASED UPON COMPARABLE MARKET RATES OF PAY WITH CONSIDERATION FOR INTERNAL EQUITY AND THE FINANCIAL POSITION OF THE ORGANIZATION. FOR THE POSITIONS OF PRESIDENT/CEO AND FOUNDER/CHAIR OF GLOBAL STRATEGY, EXTERNAL BENCHMARKING WAS CONDUCTED TO ENSURE MARKET ALIGNMENT. KOMEN PROVIDES SALARY INCREASES, PROMOTIONS AND OTHER FORMS OF COMPENSATION WITHOUT REGARD TO RACE, COLOR, RELIGION, GENDER, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS OR SEXUAL ORIENTATION. AVAIL OF GOV DOCS, CONFLICT OF INTEREST POLICY, & FIN STMTS TO GEN PUBLIC FORM 990, PART VI, QUESTION 19 KOMEN'S FINANCIAL STATEMENTS, CONFLICT OF INTEREST POLICY AND THE FORM 990 ARE PUBLICLY AVAILABLE ON OUR WEBSITE. THE CERTIFICATE OF FORMATION IS AVAILABLE FROM THE TEXAS SECRETARY OF STATE, AND OTHER GOVERNING DOCUMENTS ARE MADE AVAILABLE AS REQUIRED BY STATE LAW. FORM 1023 IS NOT ONLINE BUT IS AVAILABLE TO THE PUBLIC UPON REQUEST. ADDITIONAL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED ON OTHER EXP FORM 990, PART IX, LINE 24 Komen pays 80% of the cost of all T-shirts for the 138 Susan G. Komen race for the cure events conducted by the Komen Affiliates during the year. OTHER CHANGES IN NET ASSETS OR FUND BALANCES FORM 990, PART XI, LINE 9 RESCINDED GRANTS - $7,202,135